Definitive Contract 75F40125C00063
Award Date
9/8/25
Potential Completion Date
9/29/26
Potential Value
$516K
Federal Agency
Food and Drug Administration
Awardee
Universitat ST. Gallen
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...
The Department of Health and Human Services Food and Drug Administration awarded a $906,628.80 firm fixed price definitive contract to Universitat ST. Gallen, doing business as Hochschule Für Wirtschafts-, Rechts- und Sozialwissenschaften, to address the Broad Agency Announcement FY23C2DWP1: Predictive Continuous Improvement Acceleration towards Performance Based Regulations and Oversight. The contract responds to the FY23 FDA Broad Agency Announcement for Advanced Research and Development of...
This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
The Food and Drug Administration (FDA) awarded a $527,318.00 definitive contract to Uppsala Universitet, a Swedish educational institution, to conduct research and development on model-integrated strategies for bioequivalence evaluation of drugs with high variability and/or long half-life. This contract was awarded under the FDA's Broad Agency Announcement, which seeks proposals to advance regulatory science in various areas. The contract has no set-aside designation and is intended to support...
<p>This firm-fixed-price purchase order contract, valued at $155,000.00, was awarded by the Food and Drug Administration (FDA) to HK3 Lab S.R.L., a for-profit organization based in Italy. The contract is for an Artificial Intelligence Technical Expert, as described in the FDA's Sources Sought Notice FDA-SSN-1238254. The contract has an ultimate completion date of August 9, 2026. There is no set-aside designation mentioned. The contract was awarded on August 10, 2021.</p>
This federal contract award, valued at $480,183.00, was made by the Food and Drug Administration (FDA) to Idaho State University to conduct research and development to understand patient information needs and the factors that influence patients' perceived value and trust of healthcare artificial intelligence (AI) applications. The goal is to develop guidance for the FDA and device manufacturers to ensure information is appropriate, transparent, and supports informed decision-making. The contract...
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
This is a $494,060 Definitive Contract awarded by the Food and Drug Administration (FDA) to Drexel University, a private research university located in Philadelphia. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking research and development proposals to advance regulatory science. Specifically, the contract is for the development of "machine-learning based heterogeneous treatment effect models for prioritizing product-specific guidance development."...
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
This is a $699,087 firm-fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is for basic and applied research and development to support regulatory science and innovation, in alignment with the FDA's mission to protect and promote public health. This award is part of the FDA's agency-wide Broad Agency Announcement (BAA) for research and development. The...